X4 Pharmaceuticals, Inc. - Common Stock — movimiento trimestral de fondos (NASDAQ:XFOR) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Activos totales 146.45 M130.01 M105.17 M163.56 M290.46 M270.28 M Total de pasivos 124.3 M107.07 M101.2 M101.94 M104.17 M101.83 M Capital total 22.15 M22.94 M3.97 M61.62 M186.29 M168.45 M Total de pasivos y patrimonio neto 146.45 M130.01 M105.17 M163.56 M290.46 M270.28 M Deuda total —————— Deuda neta ——————

Noticias

Bears are Losing Control Over X4 Pharmaceuticals (XFOR), Here's Why It's a 'Buy' Now

X4 Pharmaceuticals (XFOR) Upgraded to Buy: Here's What You Should Know

X4 Pharmaceuticals (XFOR) Reports Q1 Loss, Lags Revenue Estimates

Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates

X4 Pharmaceuticals obtiene aprobación de la UE para fármaco contra el síndrome WHIM

Stifel reitera calificación de acciones de X4 Pharmaceuticals

Stifel reitera calificación de X4 Pharmaceuticals por avance en ensayo

X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates

ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates

X4 Pharmaceuticals en la Conferencia Leerink: Cambio a Hematología Rara

X4 Pharmaceuticals en Leerink: giro estratégico a hematología rara

X4 Pharmaceuticals at Leerink Global Healthcare Conference: Strategic Shift to Rare Hematology